Head and Neck Cancer

6 Jul

People with head and neck cancer whose tumors have grown may live longer if they continue treatment with an immunotherapy drug that blocks a molecule that prevents T cells in the immune system from going after cancer cells, according to a recent study. Researchers are optimistic that immunotherapy already shows promise for melanoma and lung cancer, could also lead to better outcomes for head and neck cancer patients.

Source: The Elyria Chronicle newspaper Elyria, Ohio 6-18-2017 Daniel F. Hayes, M.D., President of the American Society of Clinical Oncology (ASCO) which presented new research at its annual meeting this month

PLEASE REMEMBER TO DONATE  THANK YOU!

Leave a Reply

Your email address will not be published. Required fields are marked *

*